Beyond CeliacOct 14, 20201 minPHASE 2 STUDY RELAUNCHING IN NOVEMBERby Kate Avery, MPH, Director of Research & Patient Engagement ImmunogenX put the Solutions for Celiac study (NCT04243551) on hold in...
Celiac Disease FoundationFeb 13, 20202 minCeliac Disease Patients on a Gluten-Free Diet Still Ingest GlutenPersistent gluten exposure is known to lead to lifelong health issues in people with celiac disease, including anemia, malnutrition, and...
Beyond CeliacFeb 3, 20202 minNEW PHASE 2 CLINICAL TRIAL FOR SYMPTOMATIC CELIAC DISEASE PATIENTS LAUNCHESTesting of latiglutenase to relieve symptoms in celiac disease patients continues with the launch of a clinical trial in December This...
Beyond CeliacJan 24, 20203 minPOTENTIAL DRUG FOR CELIAC DISEASE IMPROVES SYMPTOMS AND QUALITY OF LIFE IN SOME PATIENTSStudy participants whose blood tests showed gluten exposure saw latiglutenase benefits
Celiac Disease FoundationDec 18, 20192 minLatiglutenase for Celiac Disease Shows Symptom, Quality of Life ImprovementImmunogenX, a clinical stage biotherapeutics company, has published the results of their phase 2 trial testing latiglutenase—an orally...
Beyond CeliacNov 28, 20173 minBREAKING DOWN GLUTEN TO TREAT CELIAC DISEASEInvestigation of new drug that could help patients struggling with symptoms gets NIH grant